Enhancing the quality of life of patients with inflammatory bowel disease: a multi-center study investigating cognitive behavioral therapy.
Not yet recruiting
- Conditions
- quality of life, anxiety and depression of patients with inflammatory bowel disease and cognitive behavioral therapy. Dutch: kwaliteit van leven angst en depressie bij patienten met inflammatoire darmziekten en cognitieve gedragstherapie
- Registration Number
- NL-OMON19981
- Lead Sponsor
- Schering_Plough
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
1. A diagnosis of Crohn’s disease or ulcerative colitis;
2. Age above 18;
Exclusion Criteria
1. Known psychiatric disorders that may complicate treatment (e.g., psychosis);
2. Current treatment with psychotherapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Inflammatory Bowel Disease Questionnaire (IBD-Q) will be used to assess primary outcome of the intervention. The IBD-Q measures health-related quality of life and consists of 32 items assessing four dimensions; bowel symptoms, systemic symptoms, emotional functioning, and social functioning. In addition to these four subscale scores, a total score can be calculated. <br>
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the impact of cognitive behavioral therapy on inflammatory bowel disease symptoms?
How does cognitive behavioral therapy compare to standard-of-care treatments for anxiety and depression in IBD patients?
Are there specific biomarkers that predict response to cognitive behavioral therapy in inflammatory bowel disease?
What adverse events are associated with cognitive behavioral therapy in IBD patients and how are they managed?
What combination approaches or alternative therapies are being explored alongside cognitive behavioral therapy for inflammatory bowel disease?